1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | During interview on 08/23/2023, facility staff S1 stated that resident R1 had a behavior of running throughout the facility. S1 stated the facility policy regarding use of anti-anxiety PRN medications is for staff to attempt a redirection first before administering any anti-anxiety PRN medications. S1 stated that this policy was followed with R1 when R1 would run throughout the building.
S1-S4 stated staff would attempt to redirect R1 before administering anti-anxiety PRN medications. S1 also stated during that time, there were always sufficient staff at the facility. Staff S5 stated to have provided redirections to R1 but did not have knowledge as to whether or not R1 was given anti-anxiety PRN medications. Staff S6-S7 stated to have not worked with R1.
Staff S1, S2, S3, S6, S7 stated that there were enough staff at the facility to meet the residents’ needs in the year 2020. Staff S4 and S5 stated that there were many staff shortages due to the COVID pandemic at that time.
Facility Staff Schedules from July and August 2020 show a full schedule of staff.
R1’s Physician’s Orders from 12/08/2020 state Lorazepam is a PRN medication for R1 to be used as needed for anxiety.
R1’s PRN Medication Log from 12/2020 records the interventions given prior to administering Lorazepam medication for anxiety. The interventions include “One on one,” “Music,” “Visited with Resident,” and “Photo Albums.”
This agency has investigated the complaint allegations listed. Based on interviews and review of records, the CCLD has found that the complaint allegation is unfounded, meaning that the allegation was false, could not have happened and/or is without a reasonable basis.
This report was reviewed with Steven Silacci and a copy of the report was provided.
Page 2 of 2. END REPORT. |